Bio-Techne (TECH) Other Non-Current Assets (2010 - 2026)
Bio-Techne's (TECH) quarterly Other Non-Current Assets came in at $264.4 million in Q1 2026, down 1.72% year-on-year from $269.0 million in Q1 2025, and down 1.02% quarter-over-quarter from $267.1 million in Q4 2025.
Bio-Techne (TECH) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Bio-Techne's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $264.4 million for Q1 2026.
- On a quarterly basis, Other Non-Current Assets fell 1.72% year-over-year to $264.4 million in Q1 2026; TTM through Mar 2026 was $264.4 million, a 1.72% decrease from a year earlier, with the FY2025 full-year figure at $12.3 million, down 95.33% from the prior year.
- Other Non-Current Assets retreated to $264.4 million in Q1 2026 per TECH's latest filing, from $267.1 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $285.3 million in Q2 2023 and bottomed at $1.0 million in Q4 2024.
- The 5-year median for Other Non-Current Assets is $53.9 million (2022), against an average of $145.1 million.
- Across the five-year window, Other Non-Current Assets sank 96.64% in 2024 and soared 25409.46% in 2025, its largest moves.
- Year by year, Other Non-Current Assets stood at $53.2 million in 2022, then sank by 49.91% to $26.6 million in 2023, then slumped by 96.07% to $1.0 million in 2024, then surged by 25409.46% to $267.1 million in 2025, then slipped by 1.02% to $264.4 million in 2026.
- Per Business Quant, the three latest TECH Other Non-Current Assets figures stand at $264.4 million (Q1 2026), $267.1 million (Q4 2025), and $276.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Bio-Techne | 11.23 Bn | 11.02 Bn | 208.29 Mn | 264.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 264.37 Mn |
| Dec 31, 2025 | 267.08 Mn |
| Sep 30, 2025 | 276.56 Mn |
| Jun 30, 2025 | 12.33 Mn |
| Mar 31, 2025 | 268.99 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 9.46 Mn |
| Jun 30, 2024 | 264.27 Mn |
| Mar 31, 2024 | 26.67 Mn |
| Dec 31, 2023 | 26.65 Mn |
| Sep 30, 2023 | 281.58 Mn |
| Jun 30, 2023 | 285.30 Mn |
| Mar 31, 2023 | 283.35 Mn |
| Dec 31, 2022 | 53.19 Mn |
| Sep 30, 2022 | 53.90 Mn |
| Jun 30, 2022 | 46.83 Mn |
| Mar 31, 2022 | 45.98 Mn |
| Dec 31, 2021 | 37.11 Mn |
| Sep 30, 2021 | 11.59 Mn |
| Jun 30, 2021 | 11.58 Mn |